Literature DB >> 11081198

Prolactin-producing pituitary adenoma and carcinoma with neuronal components--a metaplastic lesion.

B W Scheithauer1, E Horvath, K Kovacs, R V Lloyd, L Stefaneanu, M Buchfelder, R Fahlbusch, K von Werder, D F Lyons.   

Abstract

Recent studies indicate that cells of various epithelial tumors are capable of transformation to neurons. Observing both neurons and neuropil in two prolactin-producing adenohypophyseal tumors, one benign and one malignant, we sought to assess their cellular differentiation, the presence of nerve growth factor receptor, and expression of the dopamine receptor gene using immunocytochemistry, electron microscopy, and in situ hybridization. Light and electron microscopy clearly revealed cells morphologically transitional between adenoma/carcinoma cells and neurons. Large neurons lacked proliferative activity. Neurons in varying number showed immunoreactivity for pituitary hormones including prolactin, growth hormone and alpha subunit in the adenoma and prolactin alone in the carcinoma. The distribution of nerve growth factor receptor staining was similar. In both tumors, in situ hybridization showed mRNAs for prolactin and dopamine receptor within adenohypophyseal cells and neurons. Our results indicate that the occurrence of neurons and neuropil in growth hormone and prolactin-producing pituitary tumors appears to be the result of metaplasia. The process is not limited to benign tumors and may be due to the production of tropic substances by the adenohypophysial cells, which by paracrine/autocrine mechanisms result in transformation of adenoma cells to nerve cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 11081198     DOI: 10.1023/a:1009913303109

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  42 in total

1.  Silent somatotroph adenomas of the human pituitary. A morphologic study of three cases including immunocytochemistry, electron microscopy, in vitro examination, and in situ hybridization.

Authors:  K Kovacs; R Lloyd; E Horvath; S L Asa; L Stefaneanu; D W Killinger; H S Smyth
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

2.  Differentiating neuroblastoma of pituitary gland: neuroblastic transformation of epithelial adenoma cells. Case report.

Authors:  B Lach; P Rippstein; B G Benott; W Staines
Journal:  J Neurosurg       Date:  1996-11       Impact factor: 5.115

Review 3.  Ganglion cell-containing tumors of the pituitary gland.

Authors:  J Towfighi; M M Salam; R E McLendon; S Powers; R B Page
Journal:  Arch Pathol Lab Med       Date:  1996-04       Impact factor: 5.534

4.  Overexpression of the growth-hormone-releasing hormone gene in acromegaly-associated pituitary tumors. An event associated with neoplastic progression and aggressive behavior.

Authors:  K Thapar; K Kovacs; L Stefaneanu; B Scheithauer; D W Killinger; R V Lioyd; H S Smyth; A Barr; M O Thorner; B Gaylinn; E R Laws
Journal:  Am J Pathol       Date:  1997-09       Impact factor: 4.307

5.  A case for hypothalamic acromegaly: a clinicopathological study of six patients with hypothalamic gangliocytomas producing growth hormone-releasing factor.

Authors:  S L Asa; B W Scheithauer; J M Bilbao; E Horvath; N Ryan; K Kovacs; R V Randall; E R Laws; W Singer; J A Linfoot
Journal:  J Clin Endocrinol Metab       Date:  1984-05       Impact factor: 5.958

6.  Intrasellar gangliocytoma containing gastrin and growth hormone-releasing hormone associated with a growth hormone-secreting pituitary adenoma.

Authors:  J S Bevan; S L Asa; M L Rossi; M M Esiri; C B Adams; C W Burke
Journal:  Clin Endocrinol (Oxf)       Date:  1989-03       Impact factor: 3.478

7.  In situ hybridization study of pro-opiomelanocortin (POMC) gene expression in human pituitary corticotrophs and their adenomas.

Authors:  L Stefaneanu; K Kovacs; E Horvath; R V Lloyd
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

8.  Hypothalamic neuronal hamartoma and adenohypophyseal neuronal choristoma: their association with growth hormone adenoma of the pituitary gland.

Authors:  B W Scheithauer; K Kovacs; R V Randall; E Horvath; H Okazaki; E R Laws
Journal:  J Neuropathol Exp Neurol       Date:  1983-11       Impact factor: 3.685

Review 9.  Growth hormone-releasing hormone-producing tumors: clinical, biochemical, and morphological manifestations.

Authors:  T Sano; S L Asa; K Kovacs
Journal:  Endocr Rev       Date:  1988-08       Impact factor: 19.871

10.  Nerve growth factor in the anterior pituitary: localization in mammotroph cells and cosecretion with prolactin by a dopamine-regulated mechanism.

Authors:  C Missale; F Boroni; S Sigala; A Buriani; M Fabris; A Leon; R Dal Toso; P Spano
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

View more
  9 in total

1.  Primary sellar neuroblastoma presenting with syndrome of inappropriate secretion of anti-diuretic hormone.

Authors:  Bishan Radotra; Vasileios Apostolopoulos; Ann Sandison; Emma C I Hatfield; Nigel Mendoza; Jill Moss; Amrish Mehta; Mark Glaser; Karim Meeran; Federico Roncaroli
Journal:  Endocr Pathol       Date:  2010-12       Impact factor: 3.943

2.  The differential diagnosis of lesions involving the sella turcica.

Authors:  K Kovacs; E Horvath
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

3.  Expression pattern of neuronal intermediate filament α-internexin in anterior pituitary gland and related tumors.

Authors:  D Schult; A Hölsken; M Buchfelder; S-M Schlaffer; S Siegel; I Kreitschmann-Andermahr; R Fahlbusch; R Buslei
Journal:  Pituitary       Date:  2015-08       Impact factor: 4.107

4.  Pituitary adenoma with gangliocytic component: report of 5 cases with focus on immunoprofile of gangliocytic component.

Authors:  Serdar Balci; Arzu Saglam; Hakan Oruckaptan; Tomris Erbas; Figen Soylemezoglu
Journal:  Pituitary       Date:  2015-02       Impact factor: 4.107

5.  Combined gangliocytoma and prolactinoma of the pituitary gland.

Authors:  Shuji Mikami; Kaori Kameyama; Satoshi Takahashi; Kazunari Yoshida; Takeshi Kawase; Toshiaki Sano; Makio Mukai
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

Review 6.  Combined sellar fibrosarcoma and prolactinoma with neuronal metaplasia: report of a case unassociated with radiotherapy.

Authors:  Mario Moro; Caterina Giannini; Bernd W Scheithauer; Ricardo V Lloyd; Paul Restall; Carl Eagleton; Andrew J Law; Kalman Kovacs
Journal:  Endocr Pathol       Date:  2004       Impact factor: 3.943

Review 7.  Pituitary Gangliocytoma Producing TSH and TRH: A Review of "Gangliocytomas of the Sellar Region".

Authors:  Kiyohiko Sakata; Kana Fujimori; Satoru Komaki; Takuya Furuta; Yasuo Sugita; Kenji Ashida; Masatoshi Nomura; Motohiro Morioka
Journal:  J Clin Endocrinol Metab       Date:  2020-10-01       Impact factor: 5.958

Review 8.  Collision sellar lesions: experience with eight cases and review of the literature.

Authors:  Maria Koutourousiou; George Kontogeorgos; Pieter Wesseling; Andre J Grotenhuis; Andreas Seretis
Journal:  Pituitary       Date:  2009-06-24       Impact factor: 4.107

Review 9.  Temozolomide in aggressive pituitary adenomas and carcinomas.

Authors:  Leon D Ortiz; Luis V Syro; Bernd W Scheithauer; Fabio Rotondo; Humberto Uribe; Camilo E Fadul; Eva Horvath; Kalman Kovacs
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.